WallStreetZenWallStreetZen

NASDAQ: AMPH
Amphastar Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMPH past earnings growth

How has AMPH's earnings growth performed historically?
Company
76.58%
Industry
12.2%
Market
37.29%
AMPH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMPH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMPH's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMPH past revenue growth

How has AMPH's revenue growth performed historically?
Company
24.02%
Industry
11.16%
Market
14.21%
AMPH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMPH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMPH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMPH earnings and revenue history

Current Revenue
$601.3M
Current Earnings
$135.3M
Current Profit Margin
22.5%

AMPH Return on Equity

Current Company
23.9%
Current Industry
11.5%
Current Market
-9.5%
AMPH's Return on Equity (23.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMPH announces earnings.

AMPH Return on Assets

Current Company
12.2%
Current Industry
3.4%
AMPH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMPH Return on Capital Employed

Current Company
14.61%
Current Industry
6.2%
AMPH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMPH vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMPH$601.31M$216.41M$135.29M+17.77%+26.20%
ALVO$65.06M-$265.13M-$415.96M+425.48%N/A
BHC$8.54B$1.84B-$963.00M+0.28%N/A
PBH$1.13B$17.26M-$81.77M+2.02%N/A
INDVN/AN/AN/AN/AN/A
View Top Pharmaceutical Stocks

Amphastar Pharmaceuticals Earnings & Revenue FAQ

What were AMPH's earnings last quarter?

On Invalid Date, Amphastar Pharmaceuticals (NASDAQ: AMPH) reported Q3 2023 earnings per share (EPS) of $1.01, up 215.63% year over year. Total Amphastar Pharmaceuticals earnings for the quarter were $49.22 million. In the same quarter last year, Amphastar Pharmaceuticals's earnings per share (EPS) was $0.32.

If you're new to stock investing, here's how to buy Amphastar Pharmaceuticals stock.

What was AMPH's earnings growth in the past year?

As of Q4 2023, Amphastar Pharmaceuticals's earnings has grown 76.58% year over year. This is 64.38 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 12.2%. Amphastar Pharmaceuticals's earnings in the past year totalled $135.29 million.

What was AMPH's revenue last quarter?

On Invalid Date, Amphastar Pharmaceuticals (NASDAQ: AMPH) reported Q3 2023 revenue of $180.56 million up 50.3% year over year. In the same quarter last year, Amphastar Pharmaceuticals's revenue was $120.13 million.

What was AMPH's revenue growth in the past year?

As of Q4 2023, Amphastar Pharmaceuticals's revenue has grown 24.02% year over year. This is 12.86 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.16%. Amphastar Pharmaceuticals's revenue in the past year totalled $601.31 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.